Skip to main content

Table 1 Kaplan-Meier analysis of 41 clinical GBM patients

From: RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway

Clinicopathologic variables

Number

Average survival time

P value

All cases

41

16.475 ± 2.600

 

Age at diagnosis (years)

  

0.382

 <55

19

12.888 ± 1.908

 

  ≥ 55

22

20.189 ± 4.422

 

Gender

  

0.618

 Male

22

18.556 ± 4.335

 

 Female

19

14.289 ± 2.814

 

KPS

  

0.736

  ≤ 70

8

15.000 ± 4.979

 

 >70

33

17.698 ± 3.306

 

Headache

  

0.904

 Yes

18

12.752 ± 1.692

 

 No

23

17.195 ± 3.676

 

Intracranial infection

  

0.052

 Yes

3

6.000 ± 4.041

 

 No

38

17.352 ± 2.759

 

Multiple lesions

  

0.746

 1

33

16.708 ± 2.740

 

  ≥ 2

8

10.250 ± 1.980

 

Volume

  

0.192

  ≥ 42

20

12.075 ± 2.216

 

 <42

21

19.473 ± 4.138

 

Lobe lesions

  

0.584

 1

33

15.996 ± 2.907

 

  ≥ 2

8

17.469 ± 4.948

 

Course time(d)

  

0.151

  ≥ 30

14

10.399 ± 1.738

 

 <30

27

18.820 ± 3.488

 

RND2 expression

   

 High

20

9.307 ± 1.189

0.017*

 Low

21

21.296 ± 3.981